SHREYASKUMAR R. PATEL

258 papers receiving 19.5k citations

SHREYASKUMAR R. PATEL's Hit Papers

Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial 2017 · 1.1k citations
1.1k0+7+15Years since publication4008001.2k

Peers

SHREYASKUMAR R. PATEL
Comparison fields: 5 of 107
  • Gastroenterology 2.7k
  • Pulmonary and Respiratory Medicine 9.8k
  • Rheumatology 1.9k
  • Oncology 1.8k
  • Surgery 2.4k
Replace Sylvie Bonvalot with:
Sylvie Bonvalot France
Frits van Coevorden Netherlands
Xavier García del Muro Spain
Silvia Stacchiotti Italy
Scott M. Schuetze United States
Peter W. T. Pisters United States
Akira Kawai Japan
Sophie Piperno‐Neumann France
Sant P. Chawla United States
Philippe Alexandre Cassier France
SHREYASKUMAR R. PATEL relative to Sylvie Bonvalot France Sylvie Bonvalot's profile →
Citations per field
00.5×1.5×1.9×
Sylvie Bonvalot · 1×
Citations per year

Countries citing papers authored by SHREYASKUMAR R. PATEL

Since Specialization
Citations

This map shows the geographic impact of SHREYASKUMAR R. PATEL's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by SHREYASKUMAR R. PATEL with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites SHREYASKUMAR R. PATEL more than expected).

Fields of papers citing papers by SHREYASKUMAR R. PATEL

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by SHREYASKUMAR R. PATEL. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by SHREYASKUMAR R. PATEL. The network helps show where SHREYASKUMAR R. PATEL may publish in the future.

Co-authors

The 25 scholars most cited alongside SHREYASKUMAR R. PATEL, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with SHREYASKUMAR R. PATEL Line = papers co-authored together SHREYASKUMAR R. PATEL links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 266 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Correlation of Computed Tomography and Positron Emission Tomography in Patients With Metastatic Gastrointestinal Stromal Tumor Treated at a Single Institution With Imatinib Mesylate: Proposal of New Computed Tomography Response Criteria
Hit paper breakdown →
20071238
2
Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial
Hit paper breakdown →
20171140
3
Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial
Hit paper breakdown →
20091080
4
A Novel Classification System for Spinal Instability in Neoplastic Disease
Hit paper breakdown →
2010904
5
Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial
Hit paper breakdown →
2015681
6
Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial
Hit paper breakdown →
2016625
7
Randomized Phase II Study of Gemcitabine and Docetaxel Compared With Gemcitabine Alone in Patients With Metastatic Soft Tissue Sarcomas: Results of Sarcoma Alliance for Research Through Collaboration Study 002
Hit paper breakdown →
2007608
8
Prognostic factors for patients with localized soft‐tissue sarcoma treated with conservation surgery and radiation therapy
Hit paper breakdown →
2003560
9
We Should Desist Using RECIST, at Least in GIST
Hit paper breakdown →
2007464
10
Spinal Instability Neoplastic Score: An Analysis of Reliability and Validity From the Spine Oncology Study Group
Hit paper breakdown →
2011417
11
Clinical Risk Factors for Malignancy and Overall Survival in Patients with Pheochromocytomas and Sympathetic Paragangliomas: Primary Tumor Size and Primary Tumor Location as Prognostic Indicators
Hit paper breakdown →
2010330
12 2001322
13 2004292
14 2011276
15 2014239
16 2007222
17 2006215
18 1997209
19 2001209
20 2009207

About SHREYASKUMAR R. PATEL

SHREYASKUMAR R. PATEL is a scholar working on Pulmonary and Respiratory Medicine, Gastroenterology, Rheumatology, Oncology and Surgery, having authored 266 papers that have together received 20.2k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (169 papers), Gastrointestinal Tumor Research and Treatment (35 papers), Bone Tumor Diagnosis and Treatments (12 papers), Management of metastatic bone disease (11 papers), Cancer Immunotherapy and Biomarkers (6 papers), Soft tissue tumor case studies (6 papers), Testicular diseases and treatments (5 papers) and Adrenal and Paraganglionic Tumors (5 papers). The work is most often cited by research in Gastroenterology (2.7k citations), Pulmonary and Respiratory Medicine (9.8k citations), Rheumatology (1.9k citations), Oncology (1.8k citations) and Surgery (2.4k citations). SHREYASKUMAR R. PATEL has collaborated with scholars based in United States, Italy and Canada. Frequent co-authors include Robert S. Benjamin, Peter W. T. Pisters, Raphael E. Pollock, Matthew T. Ballo, Michael A. Burgess, Gunar K. Zagars, Robert G. Maki, Lei L. Chen, Haesun Choi and Homer A. Macapinlac. Their work appears in journals such as Cancer, Journal of Clinical Oncology, Annals of Oncology, Current Oncology Reports and The Oncologist.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact